Re-Vana Therapeutics Names Renowned International Experts to Inaugural Scientific Advisory Board
Clarendon portfolio company Re-Vana Therapeutics, a specialty ocular pharmaceutical and drug delivery company that specializes in the development of photo-crosslinked drug delivery technologies for both large and small molecules, has announced the formation of its new Scientific Advisory Board (SAB). The newly appointed SAB will strategically advise and support Re-Vana as it develops innovative therapies for […]









